Recombinant Xeno-Free Vitronectin Supports Self-Renewal and Pluripotency in Protein-Induced Pluripotent Stem Cells
- 1 February 2016
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part C: Methods
- Vol. 22 (2) , 85-90
Abstract
Patient safety is a major concern in the application of induced pluripotent stem cells (iPSCs) in cell based therapy. Efforts are being made to reprogram, maintain, and differentiate iPSCs in defined conditions in order to provide a safe source of stem cells for regenerative medicine. Recently, human fibroblasts were successfully reprogrammed into pluripotent stem cells (PSCs) using four recombinant proteins (OCT4, c-Myc, KLF4, & SOX2) fused with a cell-penetrating peptide (9R). These protein-induced pluripotent stem cells (piPSCs) are maintained and propagated on a feeder layer of mouse embryonic fibroblasts (MEF). Use of animal-derived products in maintenance and differentiation of iPSCs poses risks of zoonotic disease transmission and immune rejection when transplanted into humans. To avoid potential incorporation of xenogenic products, we cultured piPSCs on recombinant human matrix proteins. We then tested whether recombinant human matrix proteins can support self-renewal and pluripotency of piPSCs. After long term culture on recombinant human vitronectin in xeno-free conditions, piPSCs retained the expression of pluripotent markers. The pluripotency of these cells was further evaluated by differentiating towards ectoderm, mesoderm, and endoderm lineages in vitro. In conclusion, recombinant human vitronectin can support the long-term culture, and maintain the stemness of piPSCs in defined, non-xenogenic conditions.Keywords
This publication has 48 references indexed in Scilit:
- Organogenesis in a dish: Modeling development and disease using organoid technologiesScience, 2014
- Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem CellStem Cells Translational Medicine, 2014
- Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment EpitheliumCancer Informatics, 2014
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- Alternative Sources of Pluripotent Stem Cells: Ethical and Scientific Issues RevisitedStem Cells and Development, 2010
- The bioethics of stem cell research and therapyJournal of Clinical Investigation, 2010
- Nuclear Reprogramming in CellsScience, 2008
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006